PROBIOTICS BASED ON TRANSGENIC MICROORGANISMS S. А. Starovoitova, O. I. Skrotska

Details: Hits: 498

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

"Biotechnologia Acta" v. 6, no. 1, 2013
https://doi.org/ 10.15407/biotech6.01.034
Р. 34-45, Bibliography 61, Russian.
Universal Decimal classification: 579.864.1:615.331

PROBIOTICS BASED ON TRANSGENIC MICROORGANISMS

S. А. Starovoitova, O. I. Skrotska

National University of Food Technologies, Kyiv

Modern tendencies of recombinant microorganisms creation for obtaining on their basis a new effective biopreparations (probiotics) with wider spectrum of biological and therapeutic properties were considered. A lot of attention was focused on the main genera of perspective bacteria for creation of recombinant probiotics particularly: Lactococcus, Bifidobac terium,Bacillus, Escherichia. The main created Ukrainian and foreign gene-modified strains, that are widely used today in creation of effective recombinant biopreparations were characterized. Some fundamental directions and methods of gene-modified strains obtaining, which are used in getting effective biopreparations that used for therapy and prophylactic illness were reported, under which this group of pharmaceutical drugs were not used earlier. The safety matters of probiotics using on basis of genemodified strains were examined. Medical and veterinary biopreparations on basis of recombinant microorganisms could be used directly and effectively for therapy and prophylaxis of different illness, beginning from disbacteriosis up to cardiovascular diseases. It is related with some probiotic microorganisms ability for lowering of serum cholesterol at the host organism.

Key words: gene-modified microorganisms, recombinant probiotics, bacilli, bifidonacteria, lactococci, biopreparations.

References

1. Sorokulova I. B., Beliavskaia V. A., Masycgeva V. I., Smirnov V.V. Recombinant probiotics: challenges and prospects for the use in human and veterinary medicine. Vestn. Ros. AMN. 1997, No 3, P. 46–49. (In Russian).

2. Sorokulova I. B Theoretical study and practice of bacteria of the genus.For the construction of new Bacillus probiotics: Author. Thesis. Doctor. Biol. Sciences: 03.00.07. Institute of Microbiology and Virology of the NASci.Ukraine. 1999, 37 p. (In Ukrainian).

3. Yankovskii D. S. Microbial ecology of man: the modern possibilities of its maintenance and restoration. Kyiv: Ekspert LTD. 2005, 362 p. (In Russian).

4. Rybchin V.N. Basics of genetic engineering. SPb: GTU, 2002. 522 p.

5. Pat. No 26068 UA, 5 MPK A61K35/74, C12N1/21. Preventive biologic subalin. V. V. Smirnov, S. R. Reznik, I. B. Sorokulova, L. S. Sahdachchiyev, V. A. Petrenko, A. A. Ilyichov, V. A. Beliavska, I. B. Timofeev. Appl. 07.07.1993; Publ. 30.04.99, Bul No 2. (In Ukrainian).

6. Beliavska В. А., Kashperova T.A., BondarenkoВ. М. Experimental evaluation of biosafety of genetically engineered bacteria to model the strain Bacillus subtilis, producing interferon. Mikrobiol. zhurn. 2001, No 2, P. 16–20. (In Russian).

7. Popova L. Yu., Kargatova T. V., Maksimova E.E., Beliavska В. А. Adaptation of a strain of Bacillus subtilis, a recombinant plasmid containing the gene of human interferon-?2 to various conditions of existence. Mikrobiolohiya. 1997, 66(6), 761–766. (In Russian).

8. V. V. Smirnov., Sorokulova I. B, Пинчук И. В. Bacteria of the genus Bacillus - a promising source of biologically active substances. Mikrobiol. zhurn. 2001, 63(1), 72–79. (In Ukrainian).

9. Pat. No 2172343 RU, 5 MPK C12N1/20, A61K35/74, C12N1/20, C12R1:10. Strain of bacteria Bacillus licheniformis having antiviral and antibacterial activity. В. А. Beliavska, I. B. Sorokulova I. B, N. G. Romashova, Т. А. Kashperova, V. I. Masicheva, A. A. Ilichov, S. N. Shchelkunov, N. K. Danylyuk, A. E. Nesterov, L. S. Sandakhchiev, V. V. Smirnov, V. A. Petrenko, V. N. Krasnykh. Appl. 30.06.1998; Publ. 20.08.2001. (In Russian).

10. Paton A. W., Jennings M. P., Morona R. Recombinant Probiotics for Treatment and Prevention of Enterotoxigenic Escherichia coli Diarrhea. Gastroenterology. 2005, V.128 (Issue Suppl. 5), P. 1219–1228.

11. Focareta A., Paton J. C., Morona R. Recombinant Probiotic for Treatment and Prevention of Cholera. Gastroenterology. 2006, V. 130 (Issue Suppl. 6), P. 1688–1695.

12. Berlec A., Struketj B. Novel applications of recombinant lactic acid bacteria in therapy and in metabolic engineering. Rec. Patents Biotechnol. 2009, V. 3, P. 77–87.
http://dx.doi.org/10.2174/187220809788700175

13. D’Silva I. Recombinant Technology and Probiotics. Int. J. Engin. Technol. 2011,

V. 3 (Issue Suppl. 4), P. 288–293.

14. Mercenier A., Pavan S., Pot B. Probiotics as biotherapeutic agents: present knowledge

and future prospects. Cur. Pharmaceut. Design. 2002, V. 8, P. 99–110.

15. Nakayama A., Ando K., Kawamura K. Efficient secretion of the authentic mature human growth hormone by Bacillus subtilis. J. Biotechnol. 1988, V. P. 123–134.

16. Kneifel W., Salminen S. Probiotics and Health Claims. Wiley-Blackwell, 2011, 360 p.

17. Sorokulova I. B., Beliavska В. А., Masicheva V. I., Smirnov V. V. Введите текст или адрес веб-сайта либо переведите документ.

The recombinant probiotics: challenges and prospects for human and veterinary medicine. Vestn. RAMN. 1997, No 3, P. 46–49. (In Russian).

18. Sorokulova I. Preclinical testing in the deve lopment of probiotics: a regulatory perspective with Bacillus strains as an example. Clin. Infect. Dis. 2008, V. 46 (Issue Suppl. 2), P. S92–S96.

19. Sorokulova I. B., Reva O. N., Smirnov V. V. Genetic diversity and involvement in bread spoilage of Bacillus strains isolated from flour and ropy bread. Lett. Appl. Microbiol. 2003, V. 37, P. 169–173.
http://dx.doi.org/10.1046/j.1472-765X.2003.01372.x

20. Пат. No 1839459 RU, 5 МПК C12N1/21. Bacterial strain Bacillus subtilis, having antiviral and antibacterial activity. В. В. Smirnov, В. А. Beliavska, A. A. Ilichov, V. A. Petrenko, I. V. Timofeev, A. E. Netesov, S. R, Reznik, I. B. Sorokulova. Publ. 23.06.1994. (In Russian).

21. Titok M.A. Plasmids of Gram-positive bacteria. Minsk: BGU. 2004, 130 p. (In Russian).

22. Filonov A. E., Boronin A. M. Plasmid stability and competition plazmidsoderzhaschih besplazmidnyh and strains in continuous culture. Antibiot. khimioter. 1990, 35(5), 46–50. (In Russian).

23. Shchelkunov S. N. Genetic Engineering. Novosibirsk: Izd- Sib. Un-ta, 2004, 496 с. (In Russian).

24. Sorokulova I. B The study of the safety and reactogenicity of a new probiotic subalin volunteers. Mikrobiol. zhurn.1998, 60(1), 43–46. (In Russian).

25. Sorokulova I. B., Rybalko S. L., Rudenko A. A. Probiotic subalin - a fundamentally new approach to the treatment of bacterial and viral infections. — Kyiv: Nats.In-t Kharch, Prod., 2006, 36 p. (In Ukrainian).

26. Cherdintseva N. V., Litvtakov N. V., Beliavska В. А., Smolyaninov E. S. Effect of probiotic subalin recombinants on the functional activity of immune cells. Byul. eksperim. Biologii i meditsyny. 1999, 127(1), 67–70. (In Russian).

27. Chudnovskaya N.V., Rybalko S. L., Sorokulova I. B Antiviral Activity
probiotics from bacilli. Dop. NAN Ukrainy. 1995, No 2, P. 124–126. (In Ukrainian).

28. Pat. No 2035185 RU, 5 MPK А61К35/66. Preventive biopreparation subalin.

В. В. Smirnov, S. R. Reznik, I. B. Sorokulova, L.S.Sandakhiev, V. A. Petrenko, A. A. Ilichov, В. Н. Beliavska, I. V. Timofeev. Appl. 31.01.1992; Publ. 20.05.1995, Bul. No 14. (In Russian).

29. Pat. No 2159625 RU, 5 MPK A61K35/66. Actions of the complex probiotic preparation
В. А. Beliavska, T.A. Kashperova, I. B. Sorokulova, В. В. Smirnov, A. A. Ilichov, A. N. Panin, N. I. Malik, L.S.Sandakhiev. Publ. 27.11.2000. (In Russian).

30. Pat. No 2188233 RU, 5 MPK C12N1/21, A61K35/74, C12N1/21, C12R1:125. Strain of
bacteria Bacillus subtilis pBcolE2 - producer hybrid colicin E2 used for veterinary drug. M. A. Azyamov. Appl. 30.01.2000; Publ. 27.08.2002 (In Russian).

31. Pat. No 2142287 RU, 5 MPK A61K35/74, C12N1/20, C12N1/20, C12R1:07, C12R1:10, C12R1:125. Strains of bacteria Bacillus subtilis and Bacillus licheniformis used as components of the drug against viral and bacterial infections and the preparation from these strains. С. Н. Shchelkunov, V. A. Petrenko, O. I. Ryazankina, V. E. Repin, I. S. Andreeva, A. A. Ilichov, В. А. Beliavska, L. S. Sandakhiev, О. И. Serpinskiy, G. F. Sivolobova, A. N. Cinyakov, N. G. Perminova, I. V. Timofeev, A. I. Lelyak, G. A. Nosdrin, L. P. Katkovskiy, N. K. Danilyuk, V. I. Masycheva. Appl. 16.12.1997; Publ. 10.12.1999. (In Russian).

32. Baranoskiy A. Yu., Kondrashina E. A. Intestinal dysbiosis. SPb.: Piter. 2007, 240 p. (In Russian).

33. Pat. No 2144954 RU, 5 MPK C12N1/21, A61K35/74. The strain of Escherichia
Coli M 17 / pColap used to produce the probiotic preparation. V. A. Livshits, V. L. Chesnokova, V. V. Aleshin, E. V. Sokurenko, M. V. Dalin, E. G. Kravtsov, V. A. Bykov. Appl. 15.04.1998; Publ. 27.01.2000, Byul. No 13. (In Russian).

34. Khavkin A. I. Gut microbiota and the immune system. RMZh. 2003, 11(3), 122–126. (In Russian).

35. Shenderov B. A. Medical microbial ecology and functional nutrition. T. 3. Probiotics and functional food. M.: Izd. ”GRANT”. 2001, 288 p. (In Russian).

36. Bondarenko V. M., Beliavska V. A. Cloning and expression of the genes of lactobacilli. Zhurn. mikrobiol. 2000, No 2, P. 67–73. (In Russian).

7. Pat. 2388479 RF, 5 MPK A61K35/74, A61P3/06. The method of correction of hypercholesterolemia. M. R. Isaev, G. N. Tulumbetova, V. A. Batalin, B. I. Nikitenko, A. M. Che3vychalov, Yu. V. Goryachaya, A. V. Andreev, O. A. Kashirskaya, M.V. Batalina, S. B. Borisyuk. Publ. 10.05.2010. (In Russian).

38. Mosiichuk S. M., Khomenko M. B., Mikhailova T. S. Probiotics: the ability to use in hypercholesterolemia. Ukr. med. chasop. 2006, 2 (52), 10–23. (In Ukrainian).

39. Liong M. T., Shah N. P. Roles of probiotics and prebiotics on cholesterol: The hypothesized mechanisms. Nutrafoods. 2005, V. 4, P. 45–57.

40. Chralampopoulos D., Rastall R. A. Prebotics and Probiotics Science and Technology. UK: Springer, 2009, 1265 p.
http://dx.doi.org/10.1007/978-0-387-79058-9

41. Nguyen T. D., Kang J. H., Lee M. S. Characteri zation of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int. J. Food. Microbiol. 2007, V. 113, P. 358–361.
http://dx.doi.org/10.1016/j.ijfoodmicro.2006.08.015

42. Yamborka G. V., Malyunkova V. I., Petrosyants A. P. Ability of bacteria of the genus Lactobacillus remove cholesterol from the culture medium. Visn. Odes. Nats. Un-tu. 2004, 9(1), P. 249–256. (In Ukrainian).

43. Kihel N. F., Romanovskay O. M., Naumenko O. V. Studies in vitro activity holesteraznoyi lakto- and bifidobacteria as a criterion for the selection of probiotic strains. Visn. ahr. nauki. 2002, No 8, P. 59–62. (In Ukrainian).

44. Kovalenko N. K., Kasumova S. A., Muchnil F. V. Screening of strains of lactic bacteria possessing hypocholesterolemic activity, and their practical use. Mikrobiol,zhurn. 2004, 66(3), P. 33–42. (In Russian).

45. Starovoitova S. O., Oriabinska L. B., Horchakov V. Yu. Cholesterol-lowering and proteolytic activity of lactic acid bacteria in vitro. Dovkillia i zdorovia. 2007, 4 (43), P. 68–71. (In Ukrainian).

46. Starovoitova S., Kishko K., Lazarenko L. Cholesteraze activity of new lacto- and bifidobacteria strains in vitro. Nauk. visn. Uzhgor. Un-tu. Ser. biol. 2010, 27, P. 1–4. (In Ukrainian).

47. Buck M. L., Gilliland S. E. Comparison of freshly isolated strains of Lactobacillus acidophilus of human origin for ability to assimilate cholesterol during growth. J. Dairy

Sci. 1994, 77(10), 2925–2933.
http://dx.doi.org/10.3168/jds.S0022-0302(94)77233-7

48. Starovoitova S. A., Lazarenko L. N., Avdeeva L. V. Search strains of bacteria of the genera Lactobacillus and Bifidobacterium looking to create probiotics. Nauk. visn. Uzhg. un-tu. Ser. biol. 2009, V. 26, P. 216–219. (In Russian).

49. Starovoitova S. O. Development composition polishtamovoho probiotic bacteria from the genus Lactobacillus. Avtoreferat. dis. ... kand. biol. nauk: spets. 03.00.20 “Biotech”, NANU; Zabolotniy In-t mikrobiol. & Virus. Kyiv. 2008, 21 p. (In Ukrainian).

50. Starovoitova S. A., Babenko L. P., Timoshok N. A. Cholesterol-lowering activity of lactic acid bacteria probiotic strains in vivo. Mikrobiol. zhurn. 2012, 74(3), 78–84. (In Ukrainian).

51. Pat. 61954 UA, MKI А61К39/02. Method of simulation of hypercholesterolemia in mice. M. Ya. Spivak, С. О. Старовойтова — Заявл. 08.12.2010; Опубл. 10.08.2011, Бюл. No 15. (In Russian).

52. Starovoitova S. A., Babenko L. P., Shinkarenko L. N.. Development of an experimental model of hypercholesterolemia in mice. Biol. sist. 2011, 3(2), 21–23. (In Ukrainian).

53. Remaut E., Braat H., Vandenbroucke K. Clinical potential of Lactococcus lactis mediated delivery of human interleukin-10 and trfoil factors. Biosci. Microflora. 2006, V. 25, P. 81–97.
http://dx.doi.org/10.12938/bifidus.25.81

54. Steidler L., Neirynck S., Huyghebaert N. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 2003, V. 21, P. 785–789.
http://dx.doi.org/10.1038/nbt840

55. Vandenbroucke K., Hans W., Van Huysse J. et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology. 2004, V. 127, P. 502–513.
http://dx.doi.org/10.1053/j.gastro.2004.05.020

56. Starovoitova S. A., Tomoshok N. O., Spivak M. Ya., Horchakov V. Yu. Erferonogenie activity lactobacilli. Imunol. alergol. 2007, No 4, P. 24–27. (In Ukrainian).

57. Starovoitova S. A., Tomoshok N. O., Horchakov V. Yu., Spivak M. Ya. Immunomodulatory properties of bacteria of the genus Lactobacillus. Mikrobiol. zh. 2009, 71(3), P. 41–47. (In Ukrainian).

58. Pat. 67205 UA, MPK С12N 1/20. Polishtamm bacterial substance with probiotic properties. S. O. Starovoitova, L. B. Oriabincka, V. Yu. Horchakov, O. M. Gugan. Appl. 30.06.2011; Publ. 10.02.2012, Bul. No 3. (In Ukrainian).

59. Pat. 92983 UA, 5 MPK С12N1/20, C12R1/225, А61P37/02. Strain Lactobacillus delbruckii subsp. bulgaricus ІМВ-В-7281 — aktyvator of phagocytes. M. Ya. Spivak, V. S. Pidgorskii, L. M. Shinkarenko, L. N. Lazarenko, N. O. Tomoshok, V. Yu. Horchakov, S. O. Starovoitova. Appl. 13.07.2009; Publ. 11.10.2010, Bul. No 19. (In Ukrainian).

60. Пат. 93133 UA, 5 MPK С12N1/20, C12R1/245, А61P37/02. Strain Lactobacillus casei ІМВ-В-7280 — inductor of "late" interferon and activator of macrophages. M. Ya. Spivak, L. M. Shinkarenko, V. S. Pidgorskii, V. Yu. Horchakov, S. O. Starovoitova, L. N. Lazarenko, N. O. Tomoshok. Appl. 03.07.2009; Publ. 11.10.2010, Bul. No 19. (In Ukrainian).

61. Pat. 93132 UA, 5 MPK С12N1/20, C12R1/23, А61К35/74. Strain Lactobacillus acidophilus ІМВ-В-7279 — inducer of endogenous interferon type I. M. Ya. Spivak,

V. S. Pidgorskii, L. M. Shinkarenko, V. Yu. Horchakov, S. O. Starovoitova, L. N. Lazarenko, N. O. Tomoshok. Appl. 03.07.2009; Publ. 11.10.2010, Bul. No 19. (In Ukrainian).